跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 80 条关于
“CLN7”
全部
80
临床试验
50
药物
18
机构
0
资讯
12
4个月前
LifeArc Partners with Elpida Therapeutics to Advance Gene Therapies for Ultra-Rare Pediatric Neurodegenerative Diseases
去年
NCL Translational Research Conference Highlights Advances in Batten Disease Therapies
2年前
FDA Expands Brineura Approval to Include All Ages with CLN2 Disease
去年
Novel Nanoparticle Therapy Agg-CLNP Shows Promise for Preventing Rheumatoid Arthritis and Reducing Flares
去年
NICE Extends Access to Brineura for CLN2 Batten Disease While Seeking Long-term Solution
上个月
New Retina Model Reveals How CLN3-Batten Disease Damages Vision and Points to a Treatment
去年
Andelyn Biosciences Partners with Tern Therapeutics for Late-Stage Manufacturing of CLN2 Batten Disease Gene Therapy
2年前
Cullinan Therapeutics Advances CLN-978 for SLE Treatment with Phase 1 Trial Approval
9个月前
Latus Bio Receives FDA IND Clearance for LTS-101 Gene Therapy to Treat Fatal CLN2 Disease in Children
4年前
Cullinan Oncology and Taiho Pharmaceutical Forge $275M Strategic Collaboration for EGFR Inhibitor CLN-081/TAS6417
第 1 页,共 2 页
上一页
下一页